Correction to: Palui R, Sahoo J, Kamalanathan S, Kar SS, Selvarajan S, Durgia H. Effect of cabergoline monotherapy in Cushing’ disease: an individual participant data meta-analysis. J Endocrinol Invest. 2018 Dec; 41(12):1445–1455. Doi: 10.1007/s40618-018-0936-7. Epub 2018 Aug 10. PMID: 30097903

MLA

Palui, R., et al. “Correction to: Palui R, Sahoo J, Kamalanathan S, Kar SS, Selvarajan S, Durgia H. Effect of Cabergoline Monotherapy in Cushing’ Disease: An Individual Participant Data Meta-Analysis. J Endocrinol Invest. 2018 Dec; 41(12):1445–1455. Doi: 10.1007/S40618-018-0936-7. Epub 2018 Aug 10. PMID: 30097903.” Journal of Endocrinological Investigation, no. Preprints, Jan. 2022, pp. 1–2. EBSCOhost, https://doi.org/10.1007/s40618-021-01723-0.

APA

Palui, R., Sahoo, J., Kamalanathan, S., Kar, S. S., Selvarajan, S., & Durgia, H. (2022). Correction to: Palui R, Sahoo J, Kamalanathan S, Kar SS, Selvarajan S, Durgia H. Effect of cabergoline monotherapy in Cushing’ disease: an individual participant data meta-analysis. J Endocrinol Invest. 2018 Dec; 41(12):1445–1455. Doi: 10.1007/s40618-018-0936-7. Epub 2018 Aug 10. PMID: 30097903. Journal of Endocrinological Investigation, Preprints, 1–2. https://doi.org/10.1007/s40618-021-01723-0

Chicago

Palui, R., J. Sahoo, S. Kamalanathan, S. S. Kar, S. Selvarajan, and H. Durgia. 2022. “Correction to: Palui R, Sahoo J, Kamalanathan S, Kar SS, Selvarajan S, Durgia H. Effect of Cabergoline Monotherapy in Cushing’ Disease: An Individual Participant Data Meta-Analysis. J Endocrinol Invest. 2018 Dec; 41(12):1445–1455. Doi: 10.1007/S40618-018-0936-7. Epub 2018 Aug 10. PMID: 30097903.” Journal of Endocrinological Investigation, no. Preprints (January): 1–2. doi:10.1007/s40618-021-01723-0.